Javascript must be enabled to continue!
Biocompatible and sustained delivery of cinnamic acid using liposomal formulation
View through CrossRef
Cinnamic acid is an aromatic polyphenolic natural bioactive ingredient in ginseng, wheat, grains and cinnamon bark, among other substances. It is widely used in the manufacture of cosmetics, perfumes and as a flavor enhancer in the food industry. In recent years, cinnamic acid has been reported to have a variety of antibacterial, anticancer, anti-inflammatory and neuroprotective properties. Liposomes are lipid-based nanoparticles that have received considerable attention in drug delivery research due to their strong biocompatibility and low toxicity. Their resistance to degradation, as well as their potential to deliver a plethora of pharmacological loads, has prompted a substantial investigation into their medicinal applications. Researchers have been able to improve the therapeutic indices of a variety of medications by reformulating them in liposomes, particularly by modifying their biodistribution. The goal of this study is to prepare liposome-encapsulated cinnamic acid, to analyze the particles in terms of various parameters and to conduct a hemolysis assay to determine biocompatibility. The methods of characterization revealed the particles to have a spherical morphology and the sizes to be 47.2 nm (control sample) and 62.5 nm (cinnamic acid sample). The encapsulation efficiency was found to be 87.86% and the hemolysis rate at the minimum concentration of red blood cells was found to be 0.3%. Thus, the current study concludes that a natural substance (cinnamic acid) was encapsulated within a liposomal carrier, described in terms of several parameters and then used to construct a pharmacokinetic model. This demonstrates the potential benefits of using natural compounds in the treatment strategies of diabetes, cancer, microbial disorders and fungal infections, among other conditions. The inclusion of a hydrophobic medication in a carrier that the body can tolerate, opens the door to the use of comparable naturally occurring molecules as therapeutic agents in a variety of applications.
World Researchers Associations
Title: Biocompatible and sustained delivery of cinnamic acid using liposomal formulation
Description:
Cinnamic acid is an aromatic polyphenolic natural bioactive ingredient in ginseng, wheat, grains and cinnamon bark, among other substances.
It is widely used in the manufacture of cosmetics, perfumes and as a flavor enhancer in the food industry.
In recent years, cinnamic acid has been reported to have a variety of antibacterial, anticancer, anti-inflammatory and neuroprotective properties.
Liposomes are lipid-based nanoparticles that have received considerable attention in drug delivery research due to their strong biocompatibility and low toxicity.
Their resistance to degradation, as well as their potential to deliver a plethora of pharmacological loads, has prompted a substantial investigation into their medicinal applications.
Researchers have been able to improve the therapeutic indices of a variety of medications by reformulating them in liposomes, particularly by modifying their biodistribution.
The goal of this study is to prepare liposome-encapsulated cinnamic acid, to analyze the particles in terms of various parameters and to conduct a hemolysis assay to determine biocompatibility.
The methods of characterization revealed the particles to have a spherical morphology and the sizes to be 47.
2 nm (control sample) and 62.
5 nm (cinnamic acid sample).
The encapsulation efficiency was found to be 87.
86% and the hemolysis rate at the minimum concentration of red blood cells was found to be 0.
3%.
Thus, the current study concludes that a natural substance (cinnamic acid) was encapsulated within a liposomal carrier, described in terms of several parameters and then used to construct a pharmacokinetic model.
This demonstrates the potential benefits of using natural compounds in the treatment strategies of diabetes, cancer, microbial disorders and fungal infections, among other conditions.
The inclusion of a hydrophobic medication in a carrier that the body can tolerate, opens the door to the use of comparable naturally occurring molecules as therapeutic agents in a variety of applications.
Related Results
Synthesis, Characterization and evaluation of Anti-inflammatory and Antimicrobial Properties of some Cinnamic Acid Derivatives
Synthesis, Characterization and evaluation of Anti-inflammatory and Antimicrobial Properties of some Cinnamic Acid Derivatives
Background: Cinnamic acid and derivatives are widely spread in plants. They are important intermediates in the synthesis of many aromatic compounds and are known to have diverse bi...
Comparative Molecular Docking and Pharmacokinetic Profiling of Cinnamic Acid and Oleic Acid from Cinnamomum verum as Potential Inhibitors of Dengue Virus Proteins
Comparative Molecular Docking and Pharmacokinetic Profiling of Cinnamic Acid and Oleic Acid from Cinnamomum verum as Potential Inhibitors of Dengue Virus Proteins
Background: Dengue virus (DENV) does not have any effective antiviral therapy. The Cinnamomum verum has cinnamic acid and oleic acid that could inhibit important viral proteins. Ai...
Cinnamic Acid and Its Derivatives Inhibit Fructose-Mediated Protein Glycation
Cinnamic Acid and Its Derivatives Inhibit Fructose-Mediated Protein Glycation
Cinnamic acid and its derivatives have shown a variety of pharmacologic properties. However, little is known about the antiglycation properties of cinnamic acid and its derivatives...
Effect of Liposomal Lidocaine and Sucrose Alone and in Combination for Venipuncture Pain in Newborns
Effect of Liposomal Lidocaine and Sucrose Alone and in Combination for Venipuncture Pain in Newborns
OBJECTIVE:
To determine the relative effectiveness of liposomal lidocaine, sucrose, and their combination for reducing pain in term newborns.
...
A REVIEW ON PHYSICO-CHEMICAL PARAMETERS OF LIPOSOMAL DOXORUBICIN
A REVIEW ON PHYSICO-CHEMICAL PARAMETERS OF LIPOSOMAL DOXORUBICIN
The development of a generic liposomal doxorubicin product requires the study of critical physicochemical properties of the formulation. Food and Drug Administration (FDA) draft gu...
A randomized, open-label study to evaluate the efficacy and safety of liposomal amphotericin B (AmBisome) versus miltefosine in patients with post-kala-azar dermal leishmaniasis
A randomized, open-label study to evaluate the efficacy and safety of liposomal amphotericin B (AmBisome) versus miltefosine in patients with post-kala-azar dermal leishmaniasis
Background:
Treatment of post-kala-azar dermal leishmaniasis cases is of paramount importance for kala-azar elimination; however, limited treatment regimens are available as of now...
Liposomal Drug Delivery of Blumea lacera Leaf Extract: In-Vivo Hepatoprotective Effects
Liposomal Drug Delivery of Blumea lacera Leaf Extract: In-Vivo Hepatoprotective Effects
Background: Blumea lacera (B. lacera) is a herbaceous plant commonly found in south-east Asia. It shows significant therapeutic activities against various diseases. The objectives ...
Positively charged liposomal β-carotene enhances irradiation-induced cytotoxicity against prostate carcinoma cells: an in-vitro study
Positively charged liposomal β-carotene enhances irradiation-induced cytotoxicity against prostate carcinoma cells: an in-vitro study
Abstract
Interactions of β-carotene in the absence or presence of stearylamine (SA, positive charge inducer) with liposomes as model membranes were characterized....

